Hiromitsu Hayashi

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma

Kosuke Mima, Takatsugu Ishimoto, Hiromitsu Hayashi et al. · Cancer Research · 2012 · 222 citations

Medicine, Cell Biology, Oncology +17

Guidelines for Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection (JCS 2011) : Digest Version

Shinichi Takamoto, Shin Ishimaru, Masaaki Kato et al. · Japanese Circulation Journal-english Edition · 2013 · 165 citations

Medicine, Cardiology, Surgery +17

Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance

Tomoyuki Uchihara, Keisuke Miyake, Atsuko Yonemura et al. · Cancer Research · 2020 · 154 citations · Full text

Medicine, Cancer Biology, Oncology +17

JCS/JSCVS/JATS/JSVS 2020 Guideline on Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection

Hitoshi Ogino, Osamu Iida, Koichi Akutsu et al. · Circulation Journal · 2023 · 154 citations · Full text

Medicine, Cardiology, Surgery +16